Literature DB >> 2027925

Tetrahydroaminoacridine inhibits high voltage spindle activity in aged rats after acute and chronic treatment.

P Riekkinen1, M Aaltonen, P Riekkinen1.   

Abstract

The present study evaluated the ability of tetrahydroaminoacridine (THA) to reverse the age-related increase in high voltage spindles (HVS). THA was injected either 15 or 90 min before EEG recordings were made. A THA dose of 3 mg/kg IP decreased the incidence of HVS, but was ineffective at doses of 0.03 and 1 mg/kg. The HVS suppressing effect of THA (3 mg/kg) declined during a 10-day treatment period. After 10 days chronic THA treatment, a challenge dose of 6 mg/kg of THA reinstated HVS suppressing effect of THA. Our results suggests that (1) THA reverses the age-related deficit of thalamo-cortical activation (2) tolerance develops to THA-induced HVS suppression (3) anti-cholinesterase activity may be important for the efficacy of THA in decreasing HVS because pilocarpine, a muscarinic agonist, also decreased HVS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027925     DOI: 10.1007/bf02244214

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.

Authors:  K J Reinikainen; P J Riekkinen; L Paljärvi; H Soininen; E L Helkala; J Jolkkonen; M Laakso
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

2.  Effects of quisqualic acid nucleus basalis lesioning on cortical EEG, passive avoidance and water maze performance.

Authors:  P Riekkinen; J Sirviö; T Hannila; R Miettinen; P Riekkinen
Journal:  Brain Res Bull       Date:  1990-06       Impact factor: 4.077

3.  Catecholamine system involvement in age-related memory dysfunction.

Authors:  S F Zornetzer
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola.

Authors:  C L Schauf; A Sattin
Journal:  J Pharmacol Exp Ther       Date:  1987-11       Impact factor: 4.030

5.  The effects of THA on medial septal lesion-induced memory defects.

Authors:  P Riekkinen; J Sirviö; P Riekkinen
Journal:  Pharmacol Biochem Behav       Date:  1990-06       Impact factor: 3.533

6.  Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats.

Authors:  S B Dunnett; I Q Whishaw; G H Jones; S T Bunch
Journal:  Neuroscience       Date:  1987-02       Impact factor: 3.590

7.  Electric activity in the neocortex of freely moving young and aged rats.

Authors:  G Buzsáki; R G Bickford; D M Armstrong; G Ponomareff; K S Chen; R Ruiz; L J Thal; F H Gage
Journal:  Neuroscience       Date:  1988-09       Impact factor: 3.590

8.  Animal models of Alzheimer's disease: behavior, pharmacology, transplants.

Authors:  V Haroutunian; P D Kanof; G K Tsuboyama; G A Campbell; K L Davis
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

9.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

Authors:  W K Summers; L V Majovski; G M Marsh; K Tachiki; A Kling
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

10.  Effect of acute arecoline, tacrine and arecoline + tacrine post-training administration on retention in old mice.

Authors:  J F Flood; A Cherkin
Journal:  Neurobiol Aging       Date:  1988 Jan-Feb       Impact factor: 4.673

View more
  3 in total

Review 1.  Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes.

Authors:  Olivier George; Monique Vallée; Michel Le Moal; Willy Mayo
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

Review 2.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

3.  Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs.

Authors:  Nanxiang Jin; Sofya Ziyatdinova; Irina Gureviciene; Heikki Tanila
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.